We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of AVDL yet.

AVDL Hedge Fund Activity: Q2 2026 in Review

1 of the 8,153 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2026, worth a combined $16 — down 96% from $442 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AVDL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $426 sold.

  • 1 institutional investor held Avadel Pharmaceuticals (AVDL) as of Q2 2026, down from 2 in Q1 2026.
  • Funds reported $16 of Avadel Pharmaceuticals stock for Q2 2026, down 96% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q2 2026 and 1 closed out, a net change of -1 holder.
  • The largest Avadel Pharmaceuticals seller in Q2 2026 was IFP Advisors, an estimated $426 sold.

Based on aggregated 13F filings for Q2 2026.